GSK-690693

GSK-690693
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T6285-1mg 1 mg

7 - 10 business days*

42.00€
TGM-T6285-5mg 5 mg

7 - 10 business days*

97.00€
TGM-T6285-1mL 1 ml

7 - 10 business days*

97.00€
TGM-T6285-10mg 10 mg

7 - 10 business days*

139.00€
TGM-T6285-25mg 25 mg

7 - 10 business days*

278.00€
TGM-T6285-50mg 50 mg

7 - 10 business days*

445.00€
TGM-T6285-100mg 100 mg

7 - 10 business days*

659.00€
 
Description: GSK-690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM,... more
Product information "GSK-690693"
Description: GSK-690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1. Target: PKC, Serine Protease, AMPK, Autophagy, Akt. Smiles: CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N. References: Rhodes N, et al. Cancer Res, 2008, 68(7), 2366-2374.
Keywords: GSK690693
Supplier: TargetMol
Supplier-Nr: T6285

Properties

Application: pan-Akt inhibitor
MW: 425.48 D
Formula: C21H27N7O3

Database Information

CAS : 937174-76-0| Matching products
KEGG ID : K04456 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H301
P Phrases: P264, P270, P301+310, P321, P330, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK-690693"
Write a review
or to review a product.
Viewed